Cocrystal Pharma (COCP) Tax Provisions (2010 - 2018)
Cocrystal Pharma (COCP) posted Tax Provisions of -$12.1 million for Q4 2018, down 2409.94% sequentially from -$483000.0 in Q3 2018, and down 276.21% YoY from $6.9 million in Q4 2017.
Cocrystal Pharma (COCP) Tax Provisions (2010 - 2018) Analysis & Trends
Cocrystal Pharma has reported Tax Provisions for 5 years, with the latest figure at -$12.1 million in Q4 2018.
- Quarterly Tax Provisions fell 276.21% year-over-year to -$12.1 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was -$13.6 million (down 126.28% YoY) and the FY2018 annual result came in at -$13.6 million, down 97.41% from the prior year.
- Tax Provisions slipped to -$12.1 million in Q4 2018 per COCP's latest filing, from -$483000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $29.4 million in Q4 2016 and troughed at -$12.1 million in Q4 2018.
- A 4-year average of $4.2 million and a median of -$52000.0 in 2015 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2016 and 2018: Tax Provisions soared 92.12% in 2016, then sank 276.21% in 2018.
- Over 4 years, Tax Provisions stood at $15.3 million in 2015, then jumped by 92.12% to $29.4 million in 2016, then slumped by 76.59% to $6.9 million in 2017, then tumbled by 276.21% to -$12.1 million in 2018.
- According to Business Quant data, Tax Provisions over the past three periods registered -$12.1 million, -$483000.0, and -$554000.0 for Q4 2018, Q3 2018, and Q2 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -12.12 Mn |
| Sep 30, 2018 | -483,000.00 |
| Jun 30, 2018 | -554,000.00 |
| Mar 31, 2018 | -419,000.00 |
| Dec 31, 2017 | 6.88 Mn |
| Dec 31, 2016 | 29.39 Mn |
| Dec 31, 2015 | 15.30 Mn |
| Sep 30, 2015 | 104,000.00 |
| Jun 30, 2015 | -52,000.00 |
| Dec 31, 2010 | -95,945.00 |
| Sep 30, 2010 | 92,000.00 |
| Jun 30, 2010 | -40,000.00 |